Literature DB >> 19559159

Inflammation, coagulation, and the pathway to frailty.

Bindu Kanapuru1, William B Ershler.   

Abstract

There are inevitable physiologic changes associated with advancing age, yet for some people these changes are exaggerated, and as a result a phenotype emerges recognized as "frailty." Why some people become frail and others do not remains incompletely understood. Although chronic illnesses are common among frail elderly persons, some will develop all of the phenotypic features without a diagnosed underlying disease. It has been recognized that certain proinflammatory cytokines and coagulation factors are elevated to a greater extent in those who are frail than in age-matched nonfrail individuals. In this review, we provide an overview of current research in the biology of frailty with particular emphasis on the role of inflammatory pathways and disordered coagulation in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559159      PMCID: PMC5999023          DOI: 10.1016/j.amjmed.2009.01.030

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  97 in total

Review 1.  Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.

Authors:  W B Ershler; E T Keller
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

2.  White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort.

Authors:  D W Brown; W H Giles; J B Croft
Journal:  J Clin Epidemiol       Date:  2001-03       Impact factor: 6.437

3.  Antecedents of frailty over three decades in an older cohort.

Authors:  W J Strawbridge; S J Shema; J L Balfour; H R Higby; G A Kaplan
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  1998-01       Impact factor: 4.077

4.  Sex differences in the risk of frailty for mortality independent of disability and chronic diseases.

Authors:  Martine T E Puts; Paul Lips; Dorly J H Deeg
Journal:  J Am Geriatr Soc       Date:  2005-01       Impact factor: 5.562

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

6.  Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women.

Authors:  Michele Iannuzzi-Sucich; Karen M Prestwood; Anne M Kenny
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-12       Impact factor: 6.053

7.  Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study.

Authors:  Snorri B Rafnsson; Ian J Deary; Felicity B Smith; Martha C Whiteman; Ann Rumley; Gordon D O Lowe; F Gerald R Fowkes
Journal:  J Am Geriatr Soc       Date:  2007-05       Impact factor: 5.562

8.  Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).

Authors:  Matteo Cesari; Brenda W J H Penninx; Anne B Newman; Stephen B Kritchevsky; Barbara J Nicklas; Kim Sutton-Tyrrell; Russell P Tracy; Susan M Rubin; Tamara B Harris; Marco Pahor
Journal:  Am J Cardiol       Date:  2003-09-01       Impact factor: 2.778

9.  The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years. Results from the Cardiovascular Health Study.

Authors:  R P Tracy; E G Bovill; L P Fried; G Heiss; M H Lee; J F Polak; B M Psaty; P J Savage
Journal:  Ann Epidemiol       Date:  1992-07       Impact factor: 3.797

10.  Fibrin degeneration product concentrations (D-dimers) in the course of ageing.

Authors:  K Hager; D Platt
Journal:  Gerontology       Date:  1995       Impact factor: 5.140

View more
  49 in total

1.  Proteomic screening of glycoproteins in human plasma for frailty biomarkers.

Authors:  Kinza S Shamsi; Anson Pierce; Aaron S Ashton; Dipti G Halade; Arlan Richardson; Sara E Espinoza
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-01-04       Impact factor: 6.053

2.  Clinical Relevance of Differences in Glomerular Filtration Rate Estimations in Frail Older People by Creatinine- vs. Cystatin C-Based Formulae.

Authors:  Anne Jacobs; Carolien Benraad; Jack Wetzels; Marcel Olde Rikkert; Cornelis Kramers
Journal:  Drugs Aging       Date:  2017-06       Impact factor: 3.923

3.  Prevalence of aging population in the Middle East and its implications on cancer incidence and care.

Authors:  R R Hajjar; T Atli; Z Al-Mandhari; M Oudrhiri; L Balducci; M Silbermann
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

Review 4.  Translating advances from the basic biology of aging into clinical application.

Authors:  James L Kirkland
Journal:  Exp Gerontol       Date:  2012-12-10       Impact factor: 4.032

Review 5.  Incorporating biomarkers into cancer and aging research.

Authors:  Joleen M Hubbard; Harvey J Cohen; Hyman B Muss
Journal:  J Clin Oncol       Date:  2014-07-28       Impact factor: 44.544

Review 6.  Core muscle size assessed by perioperative abdominal CT scan is related to mortality, postoperative complications, and hospitalization after major abdominal surgery: a systematic review.

Authors:  Rune Hasselager; Ismail Gögenur
Journal:  Langenbecks Arch Surg       Date:  2014-02-18       Impact factor: 3.445

Review 7.  Translating the Science of Aging into Therapeutic Interventions.

Authors:  James L Kirkland
Journal:  Cold Spring Harb Perspect Med       Date:  2016-03-01       Impact factor: 6.915

Review 8.  Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.

Authors:  Tamara Tchkonia; Yi Zhu; Jan van Deursen; Judith Campisi; James L Kirkland
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

9.  Characterization of the plasma proteomic profile of frailty phenotype.

Authors:  Kristina Landino; Toshiko Tanaka; Giovanna Fantoni; Julián Candia; Stefania Bandinelli; Luigi Ferrucci
Journal:  Geroscience       Date:  2020-11-17       Impact factor: 7.713

Review 10.  Understanding immunosenescence to improve responses to vaccines.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Nat Immunol       Date:  2013-04-18       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.